| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.06 | 0.8 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.055 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.092 | 0.8 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |